Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788127 | SCV000927136 | uncertain significance | not provided | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003619720 | SCV004449174 | uncertain significance | MHC class I deficiency | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 350 of the TAPBP protein (p.Ser350Leu). This variant is present in population databases (rs374308480, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TAPBP-related conditions. ClinVar contains an entry for this variant (Variation ID: 636341). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |